News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
159,309 Results
Type
Article (8003)
Company Profile (19)
Press Release (151290)
Multimedia
Podcasts (20)
Webinars (4)
Section
Business (57537)
Career Advice (229)
Deals (9998)
Drug Delivery (41)
Drug Development (18442)
Employer Resources (33)
FDA (3722)
Job Trends (4137)
News (81222)
Policy (6068)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (2)
Academia (488)
Accelerated approval (21)
ADA (12)
Adcomms (4)
Allergies (63)
Alliances (7109)
ALS (47)
Alzheimer's disease (445)
Antibody-drug conjugate (ADC) (169)
Approvals (4049)
Artificial intelligence (147)
ASCO (86)
Autoimmune disease (111)
Automation (11)
Bankruptcy (62)
Belgium (1)
Best Places to Work (3407)
BIO (35)
Biologics (4)
BIOSECURE Act (2)
Biosimilars (56)
BioSpace Insights (22)
Biotechnology (14)
Bladder cancer (88)
Brain cancer (34)
Breast cancer (286)
Cancer (2121)
Cardiovascular disease (209)
Career advice (198)
Career pathing (8)
CAR-T (86)
CDC (14)
CDMO (33)
Celiac Disease (1)
Cell therapy (234)
Cervical cancer (20)
Clinical research (17940)
Collaboration (424)
Commercialization (2)
Company closure (3)
Compensation (1195)
Complete response letters (19)
COVID-19 (559)
CRISPR (21)
C-suite (447)
Cystic fibrosis (43)
Data (3185)
Denatured (4)
Depression (44)
Dermatology (49)
Diabetes (204)
Diagnostics (1535)
Digital health (15)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (95)
Drug pricing (49)
Drug shortages (10)
Duchenne muscular dystrophy (83)
Earnings (33929)
Editorial (14)
Employer branding (6)
Employer resources (30)
Events (21457)
Executive appointments (389)
FDA (5067)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (12)
Funding (507)
Gene editing (51)
Generative AI (14)
Gene therapy (193)
GLP-1 (385)
Government (960)
Grass and pollen (3)
Guidances (317)
Healthcare (4818)
Hematology (62)
HIV (40)
Huntington's disease (9)
IgA nephropathy (60)
Immunology and inflammation (82)
Immuno-oncology (26)
Indications (72)
Infectious disease (671)
Inflammatory bowel disease (59)
Inflation Reduction Act (4)
Influenza (33)
Intellectual property (51)
Interviews (31)
IPO (6113)
IRA (8)
Job creations (869)
Job search strategy (173)
JPM (15)
Kidney cancer (13)
Labor market (44)
Layoffs (157)
Leadership (4)
Legal (1183)
Licensing (5)
Liver cancer (21)
Longevity (5)
Lung cancer (321)
Lymphoma (209)
Machine learning (10)
Management (12)
Manufacturing (274)
Marketing (1)
MASH (67)
Medical device (3357)
Medtech (3413)
Mergers & acquisitions (4344)
Metabolic disorders (551)
mRNA (49)
Multiple sclerosis (78)
NASH (6)
Netherlands (1)
Neurodegenerative disease (126)
Neuropsychiatric disorders (38)
Neuroscience (902)
NextGen: Class of 2026 (1399)
Non-profit (1030)
Now hiring (7)
Obesity (268)
Opinion (59)
Ovarian cancer (75)
Pain (60)
Pancreatic cancer (92)
Parkinson's disease (112)
Partnered (9)
Patents (113)
Patient recruitment (154)
Peanut (23)
People (12532)
Peptides (1)
Pharmaceutical (3)
Pharmacy benefit managers (4)
Phase 1 (4495)
Phase 2 (7682)
Phase 3 (7153)
Pipeline (4589)
Policy (59)
Postmarket research (670)
Preclinical (1327)
Press Release (6)
Prostate cancer (91)
Psychedelics (18)
Radiopharmaceuticals (95)
Rare diseases (374)
Real estate (1085)
Recruiting (15)
Regulatory (5576)
Reports (25)
Research institute (474)
Resumes & cover letters (43)
Rett syndrome (10)
RNA editing (7)
RSV (26)
Schizophrenia (53)
Series A (74)
Series B (42)
Service/supplier (1)
Sickle cell disease (36)
Special edition (15)
Spinal muscular atrophy (70)
Sponsored (15)
Startups (750)
Stomach cancer (5)
Supply chain (27)
Tariffs (35)
The Weekly (16)
Vaccines (295)
Venture capital (30)
Weight loss (197)
Women's health (33)
Worklife (5)
Date
Today (40)
Last 7 days (170)
Last 30 days (616)
Last 365 days (9593)
2026 (6602)
2025 (9695)
2024 (9745)
2023 (10588)
2022 (12183)
2021 (13149)
2020 (11907)
2019 (10953)
2018 (8158)
2017 (7247)
2016 (6574)
2015 (7741)
2014 (5591)
2013 (4548)
2012 (4700)
2011 (4942)
2010 (4247)
Location
Africa (164)
Alabama (20)
Alaska (1)
Arizona (64)
Arkansas (2)
Asia (9218)
Australia (1460)
California (4528)
Canada (1369)
China (471)
Colorado (162)
Connecticut (194)
Delaware (199)
Europe (23195)
Florida (577)
Georgia (125)
Hawaii (2)
Idaho (9)
Illinois (307)
India (32)
Indiana (346)
Iowa (2)
Japan (239)
Kansas (43)
Kentucky (9)
Louisiana (21)
Maine (28)
Maryland (558)
Massachusetts (3174)
Michigan (102)
Minnesota (201)
Mississippi (2)
Missouri (39)
Montana (10)
Nebraska (5)
Nevada (42)
New Hampshire (31)
New Jersey (1395)
New Mexico (3)
New York (1224)
North Carolina (532)
North Dakota (2)
Northern California (2403)
Ohio (86)
Oklahoma (3)
Oregon (6)
Pennsylvania (916)
Puerto Rico (3)
Rhode Island (4)
South America (258)
South Carolina (18)
Southern California (1846)
Tennessee (68)
Texas (719)
United States (15904)
Utah (128)
Virginia (99)
Washington D.C. (11)
Washington State (332)
West Virginia (2)
Wisconsin (30)
159,309 Results for "25".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Edesa Biotech Announces Pricing of $25.0 Million Public Offering
August 20, 2026
·
6 min read
Press Releases
Arintra Raises $25M to Pioneer Revenue Assurance for America’s Health Systems
August 26, 2026
·
7 min read
Press Releases
Kaiser Permanente commits $25 million to Martin Luther King Jr. Community Hospital
August 11, 2026
·
5 min read
Press Releases
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - August 25, 2026
August 25, 2026
·
1 min read
Press Releases
SCYNEXIS Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - August 25, 2026
August 25, 2026
·
1 min read
Press Releases
Seek Labs Maps 25/25 Viral Families through BioSeeker, Advancing a New Model for Sequence-Directed Antiviral Discovery
June 9, 2026
·
3 min read
Press Releases
OS Therapies Granted U.S. FDA Type C Statistical Methods Meeting to Review 2.5-Year Overall Survival Data for OST-HER2 in the Prevention or Delay of Recurrence in Fully Resected, Pulmonary Metastatic Osteosarcoma
• Meeting to occur in mid-September 2026 • Interim 3-year Overall Survival data expected early September, 2026 • Decisions on appropriate comparator arm to interpret OST-HER2 clinical efficacy, RMAT designation and Rolling Review expected following this meeting • Sustained overall survival benefit observed between 2-year and 2.5-year timepoints • U.K. MHRA Statistical Methods Scientific Advice Meeting granted in parallel
August 13, 2026
·
6 min read
Earnings
GSK shares rise as $2.5B cost-cutting plan unveiled
As GSK records $2.4 billion in impairment charges for the second quarter, the U.K. pharma has announced a sweeping restructure designed to save about the same amount of money over the next few years.
July 28, 2026
·
4 min read
·
Gabrielle Masson
Press Releases
Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - August 25, 2026
August 25, 2026
·
5 min read
Earnings
Pfizer cuts $2.5B more across R&D, manufacturing in ongoing restructure
The additional cuts, which will primarily occur between 2027 and 2029, will cost some $6 billion as the pharma tries to ride out a post-COVID headache while facing stiff patent headwinds for major products like the blood thinner Eliquis.
August 4, 2026
·
3 min read
·
Annalee Armstrong
1 of 15,931
Next
